How many insider trades does FilingIQ track for CNTX?

FilingIQ tracks 31 Form 4 insider transactions for CNTX (Context Therapeutics Inc.), covering filings from Oct 22, 2021 onwards. 4 of those were filed in the last 90 days.

Are CNTX insiders net buyers or net sellers?

Across the full Form 4 history for CNTX, 19 transactions (61%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CNTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CNTX in?

Context Therapeutics Inc. (CNTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $218.21M.

CNTX insider trading

NasdaqCM Healthcare

Context Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

61% / 0%

Market cap

$218.21M

About Context Therapeutics Inc.

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Company website: www.contexttherapeutics.com

CNTX insider activity at a glance

FilingIQ has scored 31 insider transactions for CNTX since Oct 22, 2021. The most recent filing in our index is dated Feb 19, 2026.

Across the full history, 19 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CNTX insider trades is 60.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CNTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CNTX?: FilingIQ tracks 31 Form 4 insider transactions for CNTX (Context Therapeutics Inc.), covering filings from Oct 22, 2021 onwards. 4 of those were filed in the last 90 days.
Are CNTX insiders net buyers or net sellers?: Across the full Form 4 history for CNTX, 19 transactions (61%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CNTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CNTX in?: Context Therapeutics Inc. (CNTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $218.21M.

Methodology & sources

Every CNTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.